Ambry Genetics Corporation
Ambry Genetics Corporation, a leading player in the genetic testing industry, is headquartered in the United States. Founded in 2004, the company has established itself as a pioneer in clinical genetic testing, focusing on hereditary cancer, cardiovascular conditions, and other genetic disorders. With a commitment to innovation, Ambry offers a comprehensive range of services, including next-generation sequencing and genetic counselling, which are distinguished by their accuracy and depth of analysis. Operating primarily in North America, Ambry Genetics has achieved significant milestones, including the launch of its proprietary testing platforms that enhance diagnostic capabilities. The company is recognised for its robust market position, having contributed to advancements in personalised medicine and genetic research. With a dedication to improving patient outcomes, Ambry Genetics continues to set the standard in the evolving landscape of genetic healthcare.
DitchCarbon Score
How does Ambry Genetics Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ambry Genetics Corporation's score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Ambry Genetics Corporation's reported carbon emissions
Ambry Genetics Corporation, headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor does it report specific reduction targets or initiatives. The absence of emissions data suggests that the company may not have established measurable climate commitments or may be in the early stages of developing such strategies. As a current subsidiary, Ambry Genetics Corporation's climate-related data may be influenced by its corporate family relationships, but specific details regarding cascaded emissions or targets from parent organisations are not disclosed. Without concrete figures or commitments, it is challenging to assess the company's environmental impact or its alignment with industry standards for carbon reduction. In the context of the broader industry, many organisations are increasingly adopting Science-Based Targets Initiative (SBTi) guidelines and committing to net-zero emissions. However, without specific data or commitments from Ambry Genetics, it remains unclear how the company is positioning itself in relation to these trends.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Ambry Genetics Corporation is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
